Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18458-18465
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18458
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18458
Table 1 Baseline characteristics of the patients n (%)
| Characteristic | MMC group (n = 31) | “TQD” group (n = 65) | “TTK” group (n = 36) | P value |
| Age, yr, mean ± SD | 43.71 ± 9.85 | 44.94 ± 12.64 | 46.69 ± 11.86 | 0.580 |
| Male | 29 (93.55) | 51 (78.46) | 32 (88.89) | 0.114 |
| Course of disease, yr, mean ± SD | 9.87 ± 10.93 | 8.74 ± 8.48 | 10.03 ± 9.21 | 0.753 |
| Chronic liver failure | 15 (48.39) | 35 (53.85) | 14 (38.89) | 0.354 |
- Citation: Li HM, Ye ZH, Zhang J, Gao X, Chen YM, Yao X, Gu JX, Zhan L, Ji Y, Xu JL, Zeng YH, Yang F, Xiao L, Sheng GG, Xin W, Long Q, Zhu QJ, Shi ZH, Ruan LG, Yang JY, Li CC, Wu HB, Chen SD, Luo XL. Clinical trial with traditional Chinese medicine intervention ''tonifying the kidney to promote liver regeneration and repair by affecting stem cells and their microenvironment'' for chronic hepatitis B-associated liver failure. World J Gastroenterol 2014; 20(48): 18458-18465
- URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18458.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18458